We sequenced exon 5 of in principal DLBCL examples taken at medical diagnosis and relapse to look for the frequency and clinical need for mutations at that site in R-CHOP treated sufferers
We sequenced exon 5 of in principal DLBCL examples taken at medical diagnosis and relapse to look for the frequency and clinical need for mutations at that site in R-CHOP treated sufferers. protein-negative relapses take place after R-CHOP therapy but their scientific relevance is unidentified. gene. We sequenced exon 5 of in principal DLBCL samples…